Chapter 3.II: XEVPRM detailed user guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the EMA
List of industry subject matter experts and list of planned calls for industry subject matter experts
QRD Appendix V - Adverse-drug-reaction reporting details
Human medicines European public assessment report (EPAR): Hulio, adalimumab, Date of authorisation: 17/09/2018, Revision: 18, Status: Authorised
Minutes of the PRAC meeting 10-13 February 2025
Human medicines European public assessment report (EPAR): Competact, pioglitazone,metformin, Date of authorisation: 28/07/2006, Revision: 22, Status: Authorised
EU recommendations for 2025/2026 seasonal flu vaccine composition
List of medicines currently in PRIME scheme
Amended Biologics Working Party Vaccines Quality Operational Expert Group (BV-OEG) Influenza Meeting: EU recommendations for the seasonal influenza vaccine composition for the season 2025/2026
Recommendations on eligibility to PRIME scheme - Adopted at the CHMP meeting of 24-27 March 2025